Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Evogene (EVGN) Institutional Ownership

Evogene logo
$0.69 -0.03 (-3.68%)
Closing price 05/21/2026 04:00 PM Eastern
Extended Trading
$0.69 0.00 (-0.35%)
As of 08:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Evogene (NASDAQ:EVGN)

Current
Institutional Ownership
Percentage
10.40%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$66.30K
Number of
Institutional Sellers
(last 12 months)
0
Get EVGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Evogene stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

EVGN Institutional Buying and Selling by Quarter

Evogene Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026 XTX Topco Ltd22,684$25K0.0%N/A0.422%
11/17/2025 Citadel Advisors LLC57,575$66K0.0%+169.4%1.073%
5/19/2025Jane Street Group LLC33,732$42K0.0%+58.0%0.629%
5/15/2025Armistice Capital LLC316,024$395K0.0%+5.9%5.890%
2/17/2025Citadel Advisors LLC15,891$30K0.0%N/A0.296%
2/14/2025Jane Street Group LLC21,345$40K0.0%N/A0.397%
11/13/2024BNP Paribas Financial Markets12,200$37K0.0%-87.8%0.227%
10/10/2024Renaissance Investment Group LLC10,000$31K0.0%N/A0.024%
5/1/2024BNP Paribas Financial Markets91,400$69K0.0%+30.8%0.222%
11/13/2023Silverarc Capital Management LLC3,100,000$1.82M0.6%+3,000.0%7.521%
8/15/2023Silverarc Capital Management LLC100,000$107K0.0%N/A0.243%
7/27/2023Virtu Financial LLC27,333$29K0.0%N/A0.066%
10/28/2022Silverarc Capital Management LLC167,510$139K0.0%-17.2%0.407%
7/25/2022Silverarc Capital Management LLC202,322$156K0.0%-31.6%0.786%
4/20/2022Sigma Planning Corp31,410$41K0.0%+88.0%0.122%


EVGN Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Evogene shares: Armistice Capital LLC ($395K), Citadel Advisors LLC ($66K), Jane Street Group LLC ($42K), BNP Paribas Financial Markets ($37K), and Renaissance Investment Group LLC ($31K), XTX Topco Ltd ($25K).Learn more on Evogene's institutional investors.

10.40% of Evogene's stock is owned by institutional investors. Learn more on EVGN's institutional investor holdings.

The following institutional investors have purchased Evogene's stock in the last 24 months: Citadel Advisors LLC ($52.10K), Jane Street Group LLC ($33.73K), XTX Topco Ltd ($22.68K), Armistice Capital LLC ($17.74K), and Renaissance Investment Group LLC ($10K).

Institutional investors have bought a total of 58,890 shares in the last 24 months. This purchase volume represents approximately $66.30K in transactions.



This page (NASDAQ:EVGN) was last updated on 5/22/2026 by MarketBeat.com Staff.
From Our Partners